- Country: Ukraine
- Summary: Buspirone Tablets 10 Mg, Tolperisone Film-Coated Tablets 150 Mg, Lamotrigine Tablets 50 Mg, Valproic Acid Tablets 500 Mg, Amitriptyline Tablets 25 Mg
- UAT Ref No: 107228966
- Deadline: 19 Sep 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 98207.8
- Notice Type: Tender
- Document Ref. No.: UA-2024-09-14-000154-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Buspirone tablets 10 mg 6000 pieces, Tolperisone film-coated tablets 150 mg 600 pieces, Lamotrigine, tablets, 50 mg 180 pieces, Valproic acid, tablets 500 mg 1200 pieces, Amitriptyline tablets 25 mg 10000 pieces, Type: Goods, CPV: DK 021:2015:33600000-6: Pharmaceutical
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINBuspirone Tablets 10 Mg, Tolperisone Film-Coated Tablets 150 Mg, Lamotrigine Tablets 50 Mg, Valproic Acid Tablets 500 Mg, Amitriptyline Tablets 25 Mg - Ukraine Tender
The MILITARY UNIT A7011, a Government sector organization in Ukraine, has announced a new tender for Buspirone Tablets 10 Mg, Tolperisone Film-Coated Tablets 150 Mg, Lamotrigine Tablets 50 Mg, Valproic Acid Tablets 500 Mg, Amitriptyline Tablets 25 Mg. This tender is published on UkraineTenders under UAT Ref No: 107228966 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-09-19.
The estimated tender value is UAH 98207.8, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
